Coherence Neuro
PrivateLast Round
Seed
Oct 21, 2026
Est. Valuation
$40M
Total Funding Raised
$57.34M
Momentum
Top 1%
of companies Caplight tracks
Company Overview
Coherence Neuro operates in Healthcare & Life Sciences and is based in San Francisco, California. Its latest recorded funding round was a Seed round in October 2026.
Coherence Neuro is a medical technology company that designs therapeutic neurotechnology to manage cancer from inside the body.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Hardware + Subscription, Data as a Service
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Coherence Neuro Comparables
Compare Coherence Neuro with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Axoft | 78% | |
| BrainScope | 76% | |
| Persyst Development Corporation | 76% |
For institutional investors. Book with your work email.
Coherence Neuro Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Oct 21, 2026 | ||||
| Seed | Nov 4, 2025 | ||||
| Pre Seed | Mar 13, 2023 | ||||
| Grant | Aug 3, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Coherence Neuro Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Olive Capital | Seed |
| Spacewalk VC | Seed |
| Founders Fund | Seed |
| Timeless Ventures | Seed |
| Lux Capital | Seed |
| Xtal Ventures | Seed |
| Artesian | Seed |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 21, 2026
$45M round led by Founders Fund and OpenAI.
- Aug 29, 2026
Grew 19% QoQ, from 26 to 31 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- partners_withOct 27, 2026
In 2026, Coherence partners with The Royal Melbourne Hospital on a human study in Australia as it moves into clinical research.
- receives_financingOct 27, 2026
Founders Fund and the OpenAI Startup Fund co-lead Coherence's $45M Series A on Oct 22nd '26' to fund its first chronic human glioblastoma trial.
- is_developingOct 21, 2026
Coherence is developing a brain implant that can detect and treat cancer after raising $45 million from OpenAI's venture arm and Founders Fund; early human tests record 30 minutes in three patients, with seven more tests planned and a glioblastoma trial targeted in Oct '26.
- receives_financingOct 21, 2026
Coherence receives $45M in Seed financing from investors including OpenAI's startup fund and Founders Fund to develop experimental brain implants that could eventually help detect and treat cancer.
For institutional investors. Book with your work email.
Coherence Neuro Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Coherence Neuro's valuation, stock price, and market status.
Is Coherence Neuro a public or private company?
Coherence Neuro is a private company.
What is the current stock price of Coherence Neuro?
Coherence Neuro is a private company, so its shares have no public market price. Caplight tracks Coherence Neuro's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Coherence Neuro worth (valuation)?
Coherence Neuro's valuation is estimated at $40.0M based on funding round data.
Can I buy Coherence Neuro stock?
Coherence Neuro shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Coherence Neuro's last funding round?
Coherence Neuro's most recent funding round was Seed on October 21, 2026.
Who are the main investors in Coherence Neuro?
Key investors in Coherence Neuro include Founders Fund, Artesian, Blackbird Ventures, Topology Ventures.
Will Coherence Neuro IPO soon?
No public IPO plans have been announced for Coherence Neuro.
How can I track Coherence Neuro secondary market activity?
Caplight tracks bids, offers, and trades in Coherence Neuro's shares on secondary markets.